Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
The effect of metoclopramide on plasma prolactin levels was studied in 10 women in the second half of pregnancy. The IV injection of 10 mg metoclopramide produces a significant rise in prolactin in 15 minutes, a peak of up to 6.5-fold over basal levels at 30 minutes and a sustained significant elevation for at least 4 hours. The results of this study indicate that maternal plasma protein levels although elevated, are still under inhibitory control and that the prolactin releasing capacity of the pituitary is maintained during pregnancy. The elevated hyperprolactinemia induced by metoclopramide may be of help in investigating the role of prolactin in human pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/00016348109158125 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!